Building a multibillion-dollar synthetic biology industry. SynbiTECH is an international forum taking place this June in London for experts engaged in synthetic biology research, commercialisation, investment and policymaking.

SynbiTECH 2019: Building a multibillion-dollar synthetic biology industry

The must-attend international conference taking place 24-25th June 2019 in London for anyone engaged in synthetic biology investment,  commercialisation, policymaking and research.

The event will focus on the key opportunities and challenges for building a multibillion-dollar synthetic biology industry that will contribute to the fast-growing bioeconomy.

The event has an extremely high profile speaker line-up, supporting an exciting programme sure to offer unique insights into the fast-growing field of synthetic biology.

Key themes include:
• The role of synthetic biology in sustainable food production
• Sustainable bio-design and fashion
• Growing the UK bioeconomy
• Sustainable biomanufacturing
• Healthcare and therapeutics
• High impact investment opportunities in synthetic biology

Key speakers include:
• Hermann Hauser, Co-founder & Venture Partner, Amadeus Capital Partners
• Claire Bergkamp, Sustainability & Innovation Director, Stella McCartney
• Dr Rick Johnson, CEO & Founder, Global Helix LLC
• Dr Jason Kelly, Co-Founder & CEO, Ginkgo BioWorks
• Dr Irina Haivas, Principal, Atomico

Founded by SynbiCITE, the UK’s National Industrial Translation Centre for Synthetic Biology, SynbiTECH 2019 will provide a forum to drive innovative thinking and international collaboration, to determine how science and engineering – leveraged by industry, finance and policy – can create a sustainable economy through synthetic biology/engineering biology.

Subscribe to receive the latest updates and special offers from SynbiTECH: www.synbitech.com/subscribe-receive-updates